Epirubicin, Cisplatin and Continuous Infusion 5-Fluorouracil (ECF) in Locally Advanced or Metastatic Gastric Cancer: A Single Institution Experience

Enrico Aitini, F Smerieri, Marco Sorio(A. O. Ordine Mauriziano di Torino), Maurizio Cantore, Carla Rabbi, Mauro Pagani(Azienda Ospedaliera Carlo Poma), Andrea Mambrini, Annita Lusenti(Azienda Ospedaliera Carlo Poma), Franca Pari, Giovanna Cavazzini(University of Padua), Francesca Adami(Azienda Ospedaliera Carlo Poma), D. Zamagni
Tumori Journal
January 1, 2001
10.1177/030089160108700105
Cited by 8

Related Papers

Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial
|The Lancet Oncology|2020|322
Trends and challenges in the operation of pumped-storage hydropower plants
|Renewable and Sustainable Energy Reviews|2015|315
A new generation of small hydro and pumped-hydro power plants: Advances and future challenges
|Renewable and Sustainable Energy Reviews|2014|273
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial
|The Lancet|2015|202
A PSO (particle swarm optimization)-based model for the optimal management of a small PV(Photovoltaic)-pump hydro energy storage in a rural dry area
|Energy|2014|170